Stay updated on Pembrolizumab for Biliary Tract Cancer Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab for Biliary Tract Cancer Clinical Trial page.

Latest updates to the Pembrolizumab for Biliary Tract Cancer Clinical Trial page
- Check4 days agoChange DetectedRevision label updated from v3.3.3 to v3.3.4; no visible content or layout changes. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check11 days agoNo Change Detected
- Check18 days agoNo Change Detected
- Check25 days agoChange DetectedFooter now shows Revision: v3.3.3. The HHS Vulnerability Disclosure link and the previous Revision: v3.3.2 were removed.SummaryDifference0.1%

- Check47 days agoChange DetectedRevision: v3.3.2 is now displayed, replacing v3.3.1; no observable changes to study content, endpoints, contacts, or locations. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check54 days agoChange DetectedThe page now displays Revision: v3.3.1, replacing Revision: v3.2.0; this is a minor software/version update with no observable changes to study information or page layout. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check62 days agoChange DetectedRemoved the generic government funding status notice from the page header; this change does not affect the study details, eligibility criteria, or navigation. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check76 days agoChange DetectedNo significant changes detected; the Study Details page content appears unchanged between versions.SummaryDifference0.4%

Stay in the know with updates to Pembrolizumab for Biliary Tract Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab for Biliary Tract Cancer Clinical Trial page.